Philip K. Yachmetz, SVP, General Counsel at SAVIENT PHARMACEUTICALS INC (SVNT), bought 7,000 shares at $4.13 ($29K) on 2011-09-16, disclosed to the SEC on 2011-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | SELL | 2011-02-15 | $32K | — | Filing → |